These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 20082240
1. A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome. George CF, Feldman N, Zheng Y, Steininger TL, Grzeschik SM, Lai C, Inhaber N. Sleep Breath; 2011 Jan; 15(1):13-20. PubMed ID: 20082240 [Abstract] [Full Text] [Related]
2. A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing. George CF, Feldman N, Inhaber N, Steininger TL, Grzeschik SM, Lai C, Zheng Y. Sleep Med; 2010 Jan; 11(1):38-42. PubMed ID: 19897413 [Abstract] [Full Text] [Related]
3. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy. Black J, Swick T, Bogan R, Lai C, Carter LP. Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187 [Abstract] [Full Text] [Related]
4. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study. Inoue Y, Takasaki Y, Yamashiro Y. J Clin Sleep Med; 2013 Aug 15; 9(8):751-7. PubMed ID: 23946704 [Abstract] [Full Text] [Related]
6. Use of sodium oxybate (Xyrem in patients with dual diagnosis of narcolepsy and sleep apnea. Kovacević-Ristanović R, Kuźniar TJ. Sleep Med; 2010 Jan 15; 11(1):5-6. PubMed ID: 19962938 [No Abstract] [Full Text] [Related]
7. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy. Black J, Pardi D, Hornfeldt CS, Inhaber N. Sleep Med; 2009 Sep 15; 10(8):829-35. PubMed ID: 19616998 [Abstract] [Full Text] [Related]
8. Effect of sodium oxybate, modafinil, and their combination on disrupted nighttime sleep in narcolepsy. Dauvilliers Y, Roth T, Guinta D, Alvarez-Horine S, Dynin E, Black J. Sleep Med; 2017 Dec 15; 40():53-57. PubMed ID: 29221779 [Abstract] [Full Text] [Related]
9. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Pack AI, Black JE, Schwartz JR, Matheson JK. Am J Respir Crit Care Med; 2001 Nov 01; 164(9):1675-81. PubMed ID: 11719309 [Abstract] [Full Text] [Related]
10. Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing. Feldman NT. Sleep Breath; 2010 Feb 01; 14(1):77-9. PubMed ID: 19626356 [Abstract] [Full Text] [Related]
11. Placebo and modafinil effect on sleepiness in obstructive sleep apnea. Bittencourt LR, Lucchesi LM, Rueda AD, Garbuio SA, Palombini LO, Guilleminault C, Tufik S. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):552-9. PubMed ID: 18053628 [Abstract] [Full Text] [Related]
12. Pharmacologic approaches for the management of symptoms and cardiovascular consequences of obstructive sleep apnea in adults. Dopp JM, Morgan BJ. Sleep Breath; 2010 Dec 15; 14(4):307-15. PubMed ID: 20582741 [Abstract] [Full Text] [Related]
13. Evaluation of the safety of modafinil for treatment of excessive sleepiness. Roth T, Schwartz JR, Hirshkowitz M, Erman MK, Dayno JM, Arora S. J Clin Sleep Med; 2007 Oct 15; 3(6):595-602. PubMed ID: 17993041 [Abstract] [Full Text] [Related]
14. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Black JE, Hirshkowitz M. Sleep; 2005 Apr 15; 28(4):464-71. PubMed ID: 16171291 [Abstract] [Full Text] [Related]
15. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Schwartz JR, Hirshkowitz M, Erman MK, Schmidt-Nowara W. Chest; 2003 Dec 15; 124(6):2192-9. PubMed ID: 14665500 [Abstract] [Full Text] [Related]
16. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial. Büchele F, Hackius M, Schreglmann SR, Omlor W, Werth E, Maric A, Imbach LL, Hägele-Link S, Waldvogel D, Baumann CR. JAMA Neurol; 2018 Jan 01; 75(1):114-118. PubMed ID: 29114733 [Abstract] [Full Text] [Related]
17. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea. Roth T, Rippon GA, Arora S. Sleep Breath; 2008 Mar 01; 12(1):53-62. PubMed ID: 17874255 [Abstract] [Full Text] [Related]
18. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J. Clin Ther; 2006 May 01; 28(5):689-706. PubMed ID: 16861091 [Abstract] [Full Text] [Related]
19. Improvements in daytime sleepiness and disrupted nighttime sleep with once-nightly sodium oxybate in people with narcolepsy type 1 and type 2: a plain language summary. Dauvilliers Y, Roth T, Bogan R, Thorpy MJ, Morse AM, Ascencion F, Gudeman J. J Comp Eff Res; 2024 Sep 01; 13(9):e240031. PubMed ID: 39088033 [Abstract] [Full Text] [Related]
20. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy. Black J, Pardi D, Hornfeldt CS, Inhaber N. J Clin Sleep Med; 2010 Dec 15; 6(6):596-602. PubMed ID: 21206549 [Abstract] [Full Text] [Related] Page: [Next] [New Search]